Fund Activity
Fund Portfolios
Latest stock portfolios of the world's best investors and hedge funds
Fund Trends
Stocks ranked by hedge fund and large institutional investor activity
Analyst Outlook
Analyst Upside
Stocks ranked by analyst price target upside potential
Latest Price Targets
Latest analyst price targets & ratings by research analysts
Analyst Firms
Research analyst firms, their latest ratings and performance metrics
Analysts
Research analysts, their latest ratings and performance metrics
Our Indexes
Fund Manager Index
Stock index based on fund manager activity updated each quarter
Screener
Stocks
Stocks ranked by market cap, price, and more
ETFs
ETFs ranked by market cap, price, and more
News Sentiment
Stocks ranked by news sentiment from the world's best financial news sources
Search
Sign in
Sign up
CLDI.WS
Bank of America’s
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
Stock Holding History
Bank of America’s Portfolio
CLDI.WS Stock Details
CLDI.WS Fund Activity
Quarter
Market Value
Status
Shares
Shares
Change %
Trade Value
Portfolio Weight
Portfolio Position
2023
Q4
–
Sell
-50
Closed
-$11
–
7167
2023
Q3
$11
Buy
+50
New
+$11
﹤0.01%
6689
Sign up
Sign in
Fund Activity
Fund Portfolios
Latest stock portfolios of the world's best investors and hedge funds
Fund Trends
Stocks ranked by hedge fund and large institutional investor activity
Analyst Outlook
Analyst Upside
Stocks ranked by analyst price target upside potential
Latest Price Targets
Latest analyst price targets & ratings by research analysts
Analyst Firms
Research analyst firms, their latest ratings and performance metrics
Analysts
Research analysts, their latest ratings and performance metrics
Our Indexes
Fund Manager Index
Stock index based on fund manager activity updated each quarter
Screener
Stocks
Stocks ranked by market cap, price, and more
ETFs
ETFs ranked by market cap, price, and more
News Sentiment
Stocks ranked by news sentiment from the world's best financial news sources
Theme
Close